Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 3

Sponsor Class

OTHER 291NIH 56INDUSTRY 34OTHER_GOV 16UNKNOWN 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 33Esophageal Neoplasms 14Stomach Neoplasms 11Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Colorectal Neoplasms 8Small Cell Lung Carcinoma 7Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Brain Neoplasms 6Neoplasms 5Esophageal Squamous Cell Carcinoma 5Recurrence 3Nasopharyngeal Carcinoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3Head and Neck Neoplasms 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Radiation Injuries 2Papillomavirus Infections 2Carcinoma, Small Cell 2Carcinoma, Hepatocellular 2

Interventions

sintilimab 1Irinotecan 1HMPL-013 1Fecal Microbiota Transplantation 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Colonic Neoplasms × Clear all
NCT05279677 2022-08-23

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

ChineseAMS

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05074966 2021-10-12

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

ChineseAMS

Phase 3 Unknown
314 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03545711 2018-08-06

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

ChineseAMS

Phase 1/2 Unknown
42 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡